Article info

PDF

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
  1. Professor M A Kamm, St Vincent’s Hospital, University Department of Medicine, Victoria Parade, Fitzroy 3065, Melbourne, Australia; Kamm{at}ic.ac.uk
View Full Text

Citation

Kamm MA, Lichtenstein GR, Sandborn WJ, et al
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

Publication history

  • Revised January 28, 2008
  • Accepted January 28, 2008
  • First published February 13, 2008.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.